Stockscreener 앱 받기
11.27
0.09%
-0.010
Ocular Therapeutix Inc 주식(OCUL)의 최신 뉴스
Will Ocular Therapeutix Inc benefit from geopolitical trendsEarnings Risk Report & Verified Technical Trade Signals - baoquankhu1.vn
CEO Change: Will Ocular Therapeutix Inc benefit from geopolitical trendsMarket Performance Summary & Expert Verified Movement Alerts - baoquankhu1.vn
Aug Breakouts: Is Ocular Therapeutix Inc gaining market shareJuly 2025 Snapshot & Capital Efficient Trade Techniques - baoquankhu1.vn
Peering Into Ocular Therapeutix Inc's Recent Short Interest - Benzinga
Ocular Therapeutix (OCUL) Valuation Check After Mixed Recent Returns And AXPAXLI Expectations - Yahoo Finance
Understanding the Setup: (OCUL) and Scalable Risk - Stock Traders Daily
Ocular Launches, And Then Yo-Yoes, On Rumors Sanofi Is Preparing A Bigger Bid - MSN
Biotech Launches, And Then Yo-Yoes, On Sanofi Buyout Rumor - Investor's Business Daily
Ocular Therapeutix (OCUL) Shares Surge Over 11% - GuruFocus
Ocular Therapeutix, Inc. (OCUL): A Bull Case Theory - Finviz
Sanofi (SNY) Plans Enhanced Offer for Ocular Therapeutix - GuruFocus
Ocular Therapeutix (NASDAQ:OCUL) Shares Gap UpTime to Buy? - MarketBeat
Why Sanofi May Need To Top $2.4 Billion For Ocular Therapeutix (NASDAQ:SNY) - Seeking Alpha
Ocular Therapeutix Target of Unusually High Options Trading (NASDAQ:OCUL) - MarketBeat
Ocular Therapeutix Shares Surge Following Reports Of Stronger Sanofi Bid - Benzinga
Ocular Therapeutix (OCUL) Surges on Potential Sanofi Takeover Bi - GuruFocus
RBC Capital Increases Price Target for OCUL Stock Amid Optimism - StocksToTrade
Ocular Therapeutix shares rise 11.1% - marketscreener.com
Strength Seen in Ocular Therapeutix (OCUL): Can Its 6.1% Jump Turn into More Strength? - Yahoo Finance
RBC Raises Ocular Therapeutix Price Target Amid Positive Outlook - timothysykes.com
Ocular surges on report of Sanofi buyout bid - Seeking Alpha
Why Is Ocular Therapeutix (OCUL) Stock Up Premarket Today? Sanofi Bid Rejection Fuels Rally - Tokenist
OCUL Stock Back On Retail Radar With Sanofi Takeover Speculation Resurfacing - Stocktwits
Ocular Therapeutix Shows Improved Relative Price Performance; Still Shy Of Benchmark - Investor's Business Daily
Sanofi readies higher bid for Ocular Therapeutix after initial rejectionreport - Investing.com Canada
Sanofi makes fresh play for Ocular Therapeutix - La Lettre
Is It Time To Reassess Ocular Therapeutix (OCUL) After Recent Share Price Volatility? - simplywall.st
3 Reasons OCUL is Risky and 1 Stock to Buy Instead - Yahoo Finance
VIX Spike: How Ocular Therapeutix Inc stock responds to policy changesEarnings Beat & Free Daily Entry Point Trade Alerts - Bộ Nội Vụ
Take Profit: Is Ocular Therapeutix Inc 0OT stock a buy on weaknessShare Buyback & Smart Swing Trading Alerts - Bộ Nội Vụ
Ocular Therapeutix outlines AXPAXLI NDA submission timeline with SOL-1 topline data expected Q1 2026 - MSN
Trading Recap: Why analysts raise outlook for Ocular Therapeutix Inc. (0OT) stock2025 Valuation Update & Detailed Earnings Play Alerts - Bộ Nội Vụ
Ocular Therapeutix (NASDAQ:OCUL) Shares Down 6.5%Here's Why - MarketBeat
BofA bullish on Ocular Therapeutix (OCUL) as AXPAXLI targets superiority label and faster regulatory path in wet AMD - MSN
Did Focus on AXPAXLI’s Pipeline Potential Just Shift Ocular Therapeutix's (OCUL) Investment Narrative? - simplywall.st
Is Ocular Therapeutix Inc. (0OT) stock among top earnings playsTrade Risk Summary & Verified Stock Trade Ideas - Улправда
Can Ocular Therapeutix Inc. stock hit analyst price targets2025 Earnings Surprises & Real-Time Stock Price Movement Reports - Улправда
Biotech outperformance expected to continue in 2026, Baird analysts say - Proactive financial news
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) Stock Retreats 29% But Revenues Haven't Escaped The Attention Of Investors - Sahm
Published on: 2026-01-09 05:26:20 - Улправда
Published on: 2026-01-09 03:37:07 - Улправда
How Ocular Therapeutix Inc. stock reacts to job market dataCPI Data & Verified Entry Point Detection - Улправда
Published on: 2026-01-08 20:13:00 - ulpravda.ru
Ocular Therapeutix faces looming test of a more durable eye treatment - statnews.com
Is It Too Late To Consider Ocular Therapeutix (OCUL) After Recent Share Price Volatility? - Yahoo Finance
Los Angeles Daily NewsOcular Therapeutix, Inc.Common Stock (Nasdaq:OCUL) Price Chart - FinancialContent
OCUL Falls -13% In 9-Day Spree Amid Pre-Data Silence - Trefis
Ocular Therapeutix (NASDAQ:OCUL) Share Price Crosses Below Fifty Day Moving AverageHere's Why - MarketBeat
Assessing Ocular Therapeutix (OCUL) Valuation After Mixed Short-Term Weakness And Multi-Year Shareholder Gains - Sahm
Ocular Therapeutix, Inc. (OCUL) Investor Outlook: Unpacking The 109% Potential Upside - DirectorsTalk Interviews
RSI Check: How robust is Star Equity Holdings Inc FDV0 stock financial positionMarket Risk Analysis & Weekly Breakout Opportunity Watchlist - moha.gov.vn
The Technical Signals Behind (OCUL) That Institutions Follow - Stock Traders Daily
OCUL News Today | Why did Ocular Therapeutix stock go down today? - MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) Surprises With Q3 CY2025 Sales - Finviz
What to keep an eye on in 2026 - Eyes On Eyecare
BofA Bullish on Ocular Therapeutix (OCUL) as AXPAXLI Targets Superiority Label and Faster Regulatory Path in Wet AMD - Finviz
Fat Pitch FinancialsOcular Therapeutix, Inc.Common Stock (Nasdaq:OCUL) Stock Quote - FinancialContent
Ocular Therapeutix announces first patient randomized in HELIOS-3 program - MSN
Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Biotechnology Innovator with Nearly 96% Upside Potential - DirectorsTalk Interviews
Ocular Therapeutix Earnings Notes - Trefis
4.73%
0.92%
자본화:
|
볼륨(24시간):